Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Basara, N' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 54 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Roemer, E; Blau, IW; Basara, N; Kiehl, MG; Bischoff, M; Gunzelmann, S; Kirsten, D; Sanchez, H; Wocker, EL; Fauser, AA
      Toxoplasmosis, a severe complication in allogeneic hematopoietic stem celltransplantation: Successful treatment strategies during a 5-year single-center experience

      CLINICAL INFECTIOUS DISEASES
    2. Basara, N; Kiehl, MG; Fauser, AA
      New therapeutic modalities in the treatment of graft-versus-host disease

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    3. Hartert, A; Willenbacher, W; Gunzelmann, S; Roemer, E; Basara, N; Fauser, AA; Kiehl, MG
      Successful treatment of thrombocytopenia and hemolytic anemia with IvIG ina patient with lupus-like syndrome after mismatched related PBSCT

      BONE MARROW TRANSPLANTATION
    4. Blau, IAW; Basara, N; Lentini, G; Guenzelmann, S; Kirsten, D; Schmetzer, B; Bischoff, M; Roemer, E; Kiehl, MG; Fauser, AA
      Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study

      BONE MARROW TRANSPLANTATION
    5. Basara, N; Kiehl, MG; Blau, W; Romer, E; Bischoff, M; Schmetzer, B; Kirsten, D; Gunzelmann, S; Fauser, AA
      Mycophenolate mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: Four years of experience

      TRANSPLANTATION PROCEEDINGS
    6. Basara, N; Gunzelmann, S; Willenbacher, W; Fauser, AA; Kiehl, MG
      New immunosuppressants in BMT/GVHD

      TRANSPLANTATION PROCEEDINGS
    7. Willenbacher, W; Basara, N; Blau, IW; Fauser, AA; Kiehl, MG
      Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab

      BRITISH JOURNAL OF HAEMATOLOGY
    8. Remberger, M; Ringden, O; Blau, IW; Ottinger, H; Kremens, B; Kiehl, MG; Aschan, J; Beelen, DW; Basara, N; Kumlien, G; Fauser, AA; Runde, V
      No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

      BLOOD
    9. Kiehl, MG; Basara, N
      Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients

      BLOOD
    10. Basara, N; Blau, WI; Kiehl, MG; Schmetzer, B; Bischoff, M; Kirsten, D; Gunzelmann, S; Fauser, AA
      Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients

      CLINICAL TRANSPLANTATION
    11. Basara, N; Fauser, AA
      Safety profile of mycophenolate mofetil

      BONE MARROW TRANSPLANTATION
    12. Basara, N; Schmetzer, B; Blau, IW; Bischoff, M; Gunzelmann, S; Kirsten, D; Fauser, AA
      Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study

      BONE MARROW TRANSPLANTATION
    13. Blau, IW; Basara, N; Bischoff, M; Gunzelmann, S; Romer, E; Kirsten, D; Schmetzer, B; Kiehl, MG; Fauser, AA
      Second allogeneic hematopoietic stem cell transplantation as treatment forleukemia relapsing following a first transplant

      BONE MARROW TRANSPLANTATION
    14. Ringden, O; Remberger, M; Runde, V; Bornhauser, M; Blau, IW; Basara, N; Holig, K; Beelen, DW; Hagglund, B; Basu, O; Ehninger, G; Fauser, AA
      Faster engraftment of neutrophils and platelets with peripheral blood stemcells from unrelated donors: a comparison with marrow transplantation

      BONE MARROW TRANSPLANTATION
    15. Basara, N; Blau, IW; Willenbacher, W; Kiehl, MG; Fauser, AA
      New strategies in the treatment of graft-versus-host disease

      BONE MARROW TRANSPLANTATION
    16. Kiehl, MG; Shipkova, M; Basara, N; Blau, WI; Fauser, AA
      New strategies in GVHD prophylaxis

      BONE MARROW TRANSPLANTATION
    17. Fauser, AA; Basara, N; Blau, IW; Kiehl, MG
      A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study

      BONE MARROW TRANSPLANTATION
    18. Eckert, HG; Kuhlcke, K; Schilz, AJ; Lindemann, C; Basara, N; Fauser, AA; Baum, C
      Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1)

      BONE MARROW TRANSPLANTATION
    19. Miljic, P; Milosevic-Jovicic, N; Antunovic, P; Boskovic, D; Basara, N; Rolovic, Z
      Recurrent venous thrombosis in a patient with chronic lymphocytic leukemiaand acquired protein S deficiency

      HAEMATOLOGIA
    20. Kiehl, MG; Shipkova, M; Basara, N; Blau, IW; Schutz, E; Armstrong, VW; Oellerich, M; Fauser, AA
      Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite

      CLINICAL BIOCHEMISTRY
    21. Basara, N; Jelkmann, W; Schmetzer, B; Gunzelmann, S; Bischoff, M; Blau, WI; Kiehl, MG; Fauser, AA
      Plasma thrombopoietin level in patients receiving unrelated and related bone marrow and blood stem cell transplants

      THROMBOSIS AND HAEMOSTASIS
    22. Stosic-Grujicic, S; Basara, N; Dinarello, CA
      Modulatory in vitro effects of interleukin-1 receptor antagonist (IL-1Ra) or antisense oligonucleotide to interleukin-1 beta converting enzyme (ICE) on acute myeloid leukaemia (AML) cell growth

      CLINICAL AND LABORATORY HAEMATOLOGY
    23. Blau, IW; Basara, N; Serr, A; Seidl, C; Seifried, E; Fuchs, M; Bischoff, M; Roemer, E; Fauser, AA
      A second unrelated bone marrow transplant: successful quantitative monitoring of mixed chimerism using a highly discriminative PCR-STR system

      CLINICAL AND LABORATORY HAEMATOLOGY
    24. Ringden, O; Remberger, M; Runde, V; Bornhauser, M; Blau, IW; Basara, N; Holig, K; Beelen, DW; Hagglund, H; Basu, O; Ehninger, G; Fauser, AA
      Peripheral blood stem cell transplantation from unrelated donors: A comparison with marrow transplantation

      BLOOD
    25. Basara, N; Markova, J; Schmetzer, B; Blau, IW; Kiehl, MG; Bischoff, M; Kirsten, D; Fauser, AA
      Chronic eosinophilic leukemia: Successful treatment with an unrelated bonemarrow transplantation

      LEUKEMIA & LYMPHOMA
    26. BISCHOFF ME; BLAU W; WAGNER T; WAGENMANN W; DORNER O; BASARA N; FAUSER AA
      TOTAL-BODY IRRADIATION AND CYCLOPHOSPHAMIDE IS A CONDITIONING REGIMENFOR UNRELATED BONE-MARROW TRANSPLANTATION IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA AND RENAL-FAILURE ON HEMODIALYSIS

      Bone marrow transplantation
    27. BASARA N; BLAU WI; ROMER E; RUDOLPHI M; BISCHOFF M; KIRSTEN D; SANCHEZ H; GUNZELMANN S; FAUSER AA
      MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF ACUTE AND CHRONIC GVHD IN BONE-MARROW TRANSPLANT PATIENTS

      Bone marrow transplantation
    28. BASARA N; BISCHOFF M; BLAU IW; HERMANN D; ROMER E; RUDOLPHI M; KIRSTEN D; SANCHEZ H; FAUSER AA
      A 2ND UNRELATED BONE-MARROW TRANSPLANT WITH AN UNRELATED DONOR MARROW- TREATMENT OF A PATIENT WITH RELAPSED LEUKEMIA

      Bone marrow transplantation
    29. KIRSTEN D; BLAU IW; BASARA N; RUDOLPHI M; BISCHOFF M; ROEMER E; FAUSER AA
      ALLOGENEIC BMT PBSCT IN PATIENTS WITH RELAPSED OR REFRACTORY LEUKEMIAAND LYMPHOMA - A SINGLE INSTITUTION EXPERIENCE/

      Bone marrow transplantation
    30. BASARA N; BLAU W; KIEHL MG; ROMER E; RUDOLPHI M; BISCHOFF M; KIRSTEN D; SANCHEZ H; GUNZELMANN S; FAUSER AA
      THE EFFICACY AND SAFETY OF MYCOPHENOLATE MOFETIL (MMF) IN THE TREATMENT OF ACUTE AND CHRONIC GVHD IN BONE-MARROW TRANSPLANT PATIENTS

      Bone marrow transplantation
    31. RUDOLPHI M; BASARA N; FAUSER AA; BLAU IW
      SEVERE COMPLICATION AFTER ALLOGENEIC BMT - PNEUMOTHORAX AND MEDIASTINAL EMPHYSEMA IN A PATIENT WITH BOOP (BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA)

      Bone marrow transplantation
    32. Basara, N; Blau, WI; Kiehl, MG; Romer, E; Rudolphi, M; Bischoff, M; Kirsten, D; Sanchez, H; Gunzelmann, S; Fauser, AA
      Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

      TRANSPLANTATION PROCEEDINGS
    33. BASARA N; BLAU W; ROMER E; RUDOLPHI M; BISHOFF M; KIRSTEN D; SANCHEZ H; GUNZELMANN S; FAUSER AA
      MYCOPHENOLATE MOFETIL (MMF) FOR THE TREATMENT OF ACUTE AND CHRONIC GVHD IN BONE-MARROW TRANSPLANT PATIENTS

      Experimental hematology
    34. BLAU IW; HERRMANN D; SCHMETZER B; GENGENBACHER DM; BISCHOFF M; BASARA N; FAUSER AA
      ANALYSIS OF THE INCIDENCE AND SEVERITY OF ACUTE GRAFT-VERSUS-HOST DISEASE IN PATIENTS UNDERGOING ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - A SINGLE INSTITUTION OF 55 FAMILY RELATED AND UNRELATED MARROW DONOR TRANSPLANTS

      Blood
    35. RUDOLPHI M; BASARA N; BISCHOFF M; BLAU IW; GENGENBACHER DM; GUNZELMANN S; SCHMETZER B; HERRMANN D; ROMER E; KIRSTEN D; SANCHEZ H; FAUSER AA
      INDUCTION OF GRAFT VERSUS LYMPHOMA REACTION IN STAGE IV B-CELL NON-HODGKINS-LYMPHOMA AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANT- COMPARISON OF LABORATORY, RADIOLOGICAL AND CLINICAL FINDINGS

      Blood
    36. GENGENBACHER DM; BISCHOFF M; GUENZELMANN S; ROEMER E; KIRSTEN D; RUDOLPHI M; SANCHEZ H; BASARA N; BLAU IW; FAUSER AA
      MATCHED UNRELATED AND RELATED BONE-MARROW TRANSPLANTATION FOR HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID-LEUKEMIA

      Blood
    37. KIRSTEN D; BLAU IW; BASARA N; BISCHOFF M; GENGENBACHER D; FAUSER AA
      ANALYSIS OF TRANSPLANTATION RELATED MORTALITY (TRM) OF 65 PATIENTS ATHIGH-RISK RECEIVING A MUD BONE-MARROW AND OR A PERIPHERAL STEM-CELL TRANSPLANT - A SINGLE INSTITUTION EXPERIENCE/

      Blood
    38. BASARA N; BLAU W; ROMER E; RUDOLPHI M; BISCHOFF M; KIRSTEN D; SANCHEZ H; GUNZELMANN S; FAUSER AA
      MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF ACUTE AND CHRONIC GVHD IN BONE-MARROW TRANSPLANT PATIENTS

      Blood
    39. BASARA N; STOSICGRUJICIC S; SEFER D; IVANOVIC Z; ANTUNOVIC P; MILENKOVIC P
      THE INHIBITORY EFFECT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (LD78) ON ACUTE MYELOID-LEUKEMIA CELLS IN-VITRO

      Stem cells
    40. BASARA N; ANTUNOVIC P; SEFER D; RADOSEVIC N; GOTIC M
      MEGAKARYOCYTE PROGENITORS IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA ARE SENSITIVE TO COMPLEMENT

      European journal of haematology
    41. KRAGULJAC N; BOGDANOVIC A; BASARA N
      CD34 ANTIGEN EXPRESSION IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia
    42. BASARA N; STOSICGRUJICIC S; SEFER D; RADOSEVIC N; IVANOVIC Z; MILENKOVIC P
      INHIBITION OF ACUTE MYELOID-LEUKEMIA CELL-GROWTH - COMPARISON OF THE EFFECT OF MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST

      Experimental hematology
    43. LEBEURIER I; BASARA N; AIDOUDI S; AMIRAL J; CAEN JP; HAN ZC
      CARBOXY-TERMINAL PEPTIDES (C1-24 AND C-13-24 BUT NOT C1-13) OF PLATELET-FACTOR-4 INHIBIT MURINE MEGAKARYOCYTOPOIESIS, AN ACTIVITY WHICH IS NEUTRALIZED BY HEPARIN

      British Journal of Haematology
    44. STOSICGRUJICIC S; BASARA N; MILENKOVIC P; DINARELLO CA
      MODULATION OF ACUTE MYELOBLASTIC-LEUKEMIA (AML) CELL-PROLIFERATION AND BLAST COLONY FORMATION BY ANTISENSE OLIGOMER FOR IL-1-BETA CONVERTING-ENZYME (ICE) AND IL-1 RECEPTOR ANTAGONIST (IL-1RA)

      Journal of chemotherapy
    45. BASARA N; RADOSEVICRADOJKOVIC N; COLOVIC M; BOSKOVIC D; ROLOVIC Z
      IN-VITRO DRUG-SENSITIVITY OF LEUKEMIC PROGENITORS AND P-GLYCOPROTEIN EXPRESSION IN ADULT ACUTE MYELOID-LEUKEMIA - CORRELATION WITH INDUCTION TREATMENT OUTCOME

      European journal of haematology
    46. JANKOVIC S; KRAGULJAC N; BASARA N; DONFRID M; PETROVIC M
      PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - GOLDEN STANDARDS VS MODERN TECHNOLOGIES

      American journal of hematology
    47. BASARA N; STOSICGRUJICIC S; SEFER D; DINARELLO C
      INTERLEUKIN-1 BLOCKADE INVOLVES NOT ONLY ACUTE MYELOID CELL-PROLIFERATION BUT ACUTE MYELOID PROGENITORS AS WELL

      Experimental hematology
    48. ROLOVIC Z; BASARA N; GOTIC M; SEFER D; BOGDANOVIC A
      THE DETERMINATION OF SPONTANEOUS MEGAKARYOCYTE COLONY FORMATION IS ANUNEQUIVOCAL TEST FOR DISCRIMINATION BETWEEN ESSENTIAL THROMBOCYTHEMIAAND REACTIVE THROMBOCYTOSIS

      British Journal of Haematology
    49. BASARA N; STOSICGRUJICIC S; SEFER D; RADOSEVICRADOJKOVIC N; ROLOVIC Z; DINARELLO C
      EFFECT OF INTERLEUKIN-1 BLOCKADE ON ACUTE MYELOID-LEUKEMIA PROGENITORS COLONY FORMATION AND CELL-PROLIFERATION

      Experimental hematology
    50. GOTIC M; BASARA N; ROLOVIC Z; BOSKOVIC D; ANTUNOVIC P; MARISAVLJEVIC D; BRKIC S
      SUCCESSFUL TREATMENT OF REFRACTORY PURE RED-CELL APLASIA SECONDARY TOCHRONIC LYMPHOCYTIC-LEUKEMIA WITH CYCLOSPORINE-A - CORRELATION BETWEEN CLINICAL AND IN-VITRO EFFECTS

      Nouvelle revue francaise d'hematologie
    51. SHEN ZX; BASARA N; XI XD; CAEN J; MAFFRAND JP; PASCAL M; PETITOU M; LORMEAU JC; HAN ZC
      FRAXIPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN, STIMULATES MEGAKARYOCYTOPOIESIS IN-VITRO AND IN-VIVO IN MICE

      British Journal of Haematology
    52. BASARA N; ROLOVIC Z; RADOSEVICRADOJKOVIC N; COLOVIC M; BOSKOVIC D
      P-GLYCOPROTEIN EXPRESSION AND CLONOGENIC CELL DRUG-SENSITIVITY IN ADULT ACUTE MYELOID-LEUKEMIA - CORRELATION WITH INDUCTION TREATMENT OUTCOME

      Experimental hematology
    53. ROLOVIC Z; BASARA N; PAVLOVICKENTERA V; BILJANOVICPAUNOVIC L; VASILJEVSKA M
      THE EXTENT OF ANEMIA IN BELGRADE (B B) RAT

      Experimental hematology
    54. ZUNIC G; ROLOVIC Z; BASARA N; SIMOVIC M; VASILJEVSKI M
      DECREASED PLASMA-PROTEINS, INCREASED TOTAL PLASMA-FREE AMINO-ACIDS, AND DISTURBED AMINO-ACID-METABOLISM IN THE HEREDITARY SEVERE ANEMIA OF THE BELGRADE LABORATORY (B B) RAT/

      Proceedings of the Society for Experimental Biology and Medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 13:47:15